Since TMPRSS2 is expressed in the prostate and regulated by androgens, its fusion to the transcriptional activators ETS gene products could result in driving prostate cancer development, and it appears that this is in fact the case. The gene discussed is TMPRSS2; the disease is Familial prostate cancer.